137685-69-9

Upstream product

• 81250-33-1 1,3-di-n-propyl-5-nitroso-6-aminouracil 
• 41862-14-0 6-amino-1,3-dipropyluracil 
• 81250-34-2 1,3-dipropyl-5,6-diaminouracil 
• 90-27-7 2-Phenylbutyric acid 
• 36854-57-6 2-Phenylbutyryl chloride 
• 137685-86-0 N-(6-Amino-2,4-dioxo-1,3-dipropyl-1,2,3,4-tetrahydro-pyrimidin-5-yl)-2-phenyl-butyramide 

Relevant academic research and scientific papers

XANTHINE DERIVATIVES AS ADENOSINE A1 RECEPTOR ANTAGONISTS

A method of attenuating a cognitive deficit in a patient in need thereof comprising administering to the patient a xanthine derivative.

Selective adenosine receptor agents

Xanthine derivative which act selectively at adenosine receptors and which act in general as adenosine antagonists are disclosed. From in vitro studies it is known that specific physiological effects can be distinguished as a result of this selectively and that adenosine receptor activity in vitro correlates with adenosine receptor activity in vivo.Pharmaceutical preparations of the subject compounds can be prepared on the basis of the selective binding activity of the compounds disclosed herein which will enhance certain physiological effects while minimizing others, such as decreasing blood pressure without decreasing heart rate.